Nonrulemaking

Requests that the FDA declare that Hydrocortisone Tablets, 2.5 mg, 7.5 mg, and 15 mg, are suitable for submission as an ANDA. As designated in FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) the Reference Listed Drug (RLD) upon which this petition is based is Pharmacia & Upjohn Co.s (Pfizer, Inc.s) CORTEF (hydrocortisone) Tablets, which is approved for

Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

No documents mirrored for this docket yet.

© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets